<DOC>
	<DOCNO>NCT02217228</DOCNO>
	<brief_summary>Prospective , randomized multicenter study examine safety effectiveness Sebacia microparticles without laser treatment moderate moderately-severe inflammatory acne vulgaris</brief_summary>
	<brief_title>Pivotal Study Sebacia Microparticles Treatment Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Males female , 15 45 year age Able provide inform consent/assent ; minor provide assent parent legal guardian provide consent Moderate moderately severe ( 3 4 ) inflammatory acne vulgaris Investigator 's Global Assessment Subject 25 75 inflammatory lesion cheek , chin forehead , concentrate one area Subject Fitzpatrick skin phototype I , II III Subject good health , willing participate able comply protocol requirement Severe acne ( Investigator 's Global Assessment 5 ) significant scar potential great 2 nodular lesion Clinically relevant history keloid Facial tattoo Acne conglobata , acne fulminans , chloracne , druginduced acne Active concomitant skin disease , excessive scar excess facial hair Heavily tan skin ; unable unwilling avoid tan beds/excessive sun exposure Acne medication therapy restriction time period prior Baseline ( ) 1 . Oral retinoids 6 month 2 . Other systemic medication 4 week 3 . Topical retinoids , steroid , antibiotic 2 week 4 . OTC topical treatment 1 week 5 . Light treatment ( include IPL laser ) , microdermabrasion and/or peel 8 week 6 . Investigational drug , biologic device 30 day 7 . Gold therapy type reason EXCLUDED Pregnant , lactating , nurse plan become pregnant study period Known allergy gold , ethanol , diisopropyl adipate , Polysorbate 80 Clinically relevant condition make participation unsafe would interfere study treatment assessment</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>